Search
+
    SEARCHED FOR:

    CANCER TREATMENTS

    ‘A man in a leather jacket who treated employees like human beings’: Nvidia VP recalls how Jensen Huang went out of his way to help him fight ‘nasty’ cancer, winning hearts online

    John Zedlewski, an Nvidia executive, detailed his struggle with cancer and Jensen Huang's support during that time. After Zedlewski informed Huang of his condition, Huang reached out to Stanford University to assist him. Despite recent scandals regarding Huang's personal life, Zedlewski defended his former CEO's character and compassion towards employees. Huang’s resignation followed reports of unfaithfulness and concerns involving staff members, raising significant scrutiny.

    Robyn Coffin, known for her role as Cindy Herrmann on Chicago Fire, has been diagnosed with breast cancer. A fundraiser titled 'Standing with Robyn Through Surgery and Recovery' has raised $15,298 to support her medical expenses. Robyn is scheduled for surgery on December 3, 2026, and her recovery may require additional time off work.

    UK's Prince William to be joined by wife Kate for India visit this week

    Princess Kate and Prince William will travel to India for the Earthshot Prize awards this week. This trip signifies her most prominent foreign visit since recovering from cancer treatment in 2024. The awards ceremony will feature notable celebrities, including Sachin Tendulkar and Rami Malek. The royals will also engage in events related to cricket, fashion, and cinema.

    18 patent applications for HIV drug lenacapavir may delay affordable generics in India

    Gilead Sciences has filed 18 patent applications in India for lenacapavir, raising concerns among patient groups. They argue these applications may hinder the availability of affordable generic versions of the HIV drug. Consumer advocates have approached the patent office, seeking a rejection of these filings as they may constitute evergreening. If granted, these patents could remain valid until 2042, extending exclusive rights.

    Compulsory licensing of drugs only after exhausting all other measures: Department of Pharmaceuticals secretary Manoj Joshi

    The government plans to address the high costs of innovative medicines by first negotiating prices. Compulsory licensing will be considered only after other alternatives are exhausted. Trade margins on high-cost drugs are being examined to enhance affordability. Discussions are ongoing with pharmaceutical companies to improve access and affordability of patented drugs. The government is also working on initiatives to support the local pharmaceutical manufacturing sector.

    These large-, mid- and small-cap stocks have upside potential of more than 20% in 1 year, according to analysts

    The probability of a sharp, damaging downturn now appears low, and the broad direction favours the market. So, the stance should be the same as in these past few weeks: Shedding fear, but cautiously optimistic. Focus on the business under the stock you are interested in, and keep one eye on what is happening globally.

    The Economic Times
    BACK TO TOP